Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.76 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.76 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.76 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | NPC1 | O15118 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30262243 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL8490844 | 0.96 | SMN1; SMN2 (0.92) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL27737323 | 0.87 | ADORA2A (1.00) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| Toluene SCHEMBL27904873 | 0.85 | SMN1; SMN2 (0.73) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| Chlorobenzene SCHEMBL27904895 | 0.85 | SMN1; SMN2 (0.73) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL195530 | 0.84 | SMN1; SMN2 (0.71) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL17046876 | 0.84 | SMN1; SMN2 (0.71) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL29502789 | 0.84 | SMN1; SMN2 (0.71) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL30468191 | 0.84 | SMN1; SMN2 (0.71) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL31683760 | 0.82 | SMN1; SMN2 (0.69) | SMN1; SMN2ADORA2AADORA3ADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638972-B | Novel compositions and methods for producing alkoxylated triazine-arylhydroxy-aldehyde condensates | 巴克莱特英国控股有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-111108136-B | Compositions for polyurethane applications | 巴克莱特英国控股有限公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-2606037-B1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES WITH IMPROVED SOLUBILITY | BAKELITE UK HOLDING LTD (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-3833699-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE ALKOXYLATED TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES | Hexion Research Belgium SA (BE) | 2021-06-16 | — | — | EP | disclosed |
| US-11028219-B2 | Compositions for polyurethane applications | HEXION INC. (US) | 2021-06-08 | — | — | US | disclosed |
| EP-3827040-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE ALKOXYLATED TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES | Hexion Research Belgium SA (BE) | 2021-06-02 | — | — | EP | disclosed |
| CN-112673036-A | Novel compositions and methods for producing alkoxylated triazine-arylhydroxy-aldehyde condensates | 瀚森公司 | 2021-04-16 | — | — | CN | disclosed |
| CN-112638972-A | Novel compositions and methods for producing alkoxylated triazine-arylhydroxy-aldehyde condensates | 瀚森公司 | 2021-04-09 | — | — | CN | disclosed |
| EP-3684830-A1 | NOVEL COMPOSITIONS FOR POLYURETHANE APPLICATIONS | Hexion Inc. (US) | 2020-07-29 | — | — | EP | disclosed |
| EP-3684760-A2 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE ALKOXYLATED TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES | Hexion Research Belgium SA (BE) | 2020-07-29 | — | — | EP | disclosed |
| US-20120046424-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES WITH IMPROVED SOLUBILITY | HEXION SPECIALTY CHEMICALS, INC. | 2012-02-23 | — | — | US | disclosed |
| WO-2012024210-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES WITH IMPROVED SOLUBILITY | MOMENTIVE SPECIALTY CHEMICALS INC. (US) | 2012-02-23 | — | — | WO | disclosed |
| EP-1193513-B1 | Method of producing color filter | DAINIPPON INK & CHEMICALS (JP) | 2008-12-03 | — | — | EP | disclosed |
| EP-1174765-B1 | Color filter and method for producing the same | DAINIPPON INK & CHEMICALS (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-6929827-B2 | Method of producing color filter | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-08-16 | — | — | US | disclosed |
| US-6524757-B2 | Forming pattern using alkaline developers; photopolymerization | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-02-25 | — | — | US | disclosed |
| US-20020081376-A1 | Method of producing color filter | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-06-27 | — | — | US | disclosed |
| EP-1193513-A2 | Method of producing color filter | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-04-03 | — | — | EP | disclosed |
| US-20020025481-A1 | Color filter and method for producing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-02-28 | — | — | US | disclosed |
| EP-1174765-A1 | Color filter and method for producing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11028219-B2 | Compositions for polyurethane applications | ALKBH3, ALKBH2, XRCC5 | SMN1; SMN2 2722/4885ADORA2A 4687/4885ADORA3 4804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.